Previous Close | 37.80 |
Open | 38.20 |
Bid | 38.20 x 100000 |
Ask | 39.60 x 100000 |
Day's Range | 38.20 - 38.20 |
52 Week Range | 30.80 - 39.80 |
Volume | |
Avg. Volume | 1 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PALO ALTO, Calif., November 10, 2023--Recor Medical, Inc. announces the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation system for the treatment of hypertension.
PALO ALTO, Calif., November 08, 2023--Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
PALO ALTO, Calif., October 26, 2023--Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., announced positive results in a late-breaking session at TCT 2023.